Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe
Identifieur interne : 000557 ( PascalFrancis/Corpus ); précédent : 000556; suivant : 000558Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe
Auteurs : O. Donoso Mantke ; H. Schmitz ; H. Zeller ; P. Heyman ; A. Papa ; M. NiedrigSource :
- EUROSURVEILLANCE. EUROPEAN COMMUNICABLE DISEASE QUARTERLY [ 1025-496X ] ; 2005-04.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
The threat posed by emerging and re-emerging communicable diseases and, more recently, by the intentional release of infectious agents in a susceptible population, has been receiving considerable attention at the national and international levels. Public health efforts to strengthen disease detection, surveillance and control have been intensified. However, clinicians and clinical microbiology laboratories play an important role in the early detection of disease, the identification of the putative agent, and notification of the appropriate authorities. To be effective in this role, laboratories must be specially prepared to handle viral agents safely, and need, among other things, the appropriate rapid and sensitive diagnostic tests. In 1998 the European Network for Diagnostics of "Imported" Viral Diseases (ENIVD) was established. ENIVD presently comprises, as permanent members, 44 expert laboratories in 21 European Union (EU) member states and 4 non-EU countries and is one of the networks on infectious diseases funded by the European Commission. ENIVD fulfils many of the important tasks required for the surveillance and control of imported, rare and emerging viral infections such as the exchange of expertise and the organisation of external quality assurance (EQA) programmes, both of which are needed to improve diagnostics. Here, we summarise the data generated by recent EQA activities focussed on the diagnostics of infections with hantavirus, dengue virus, filovirus, Lassa virus, orthopox virus and the SARS-coronavirus (SARS-CoV). These were carried out between 1999 and 2004 and involved 93 laboratories from 41 countries, including laboratories from additional countries outside of Europe. Particularly the EU-candidate countries and Eastern neighbouring countries will be invited to join the network in the near future. (R.A.)
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
|
---|
Format Inist (serveur)
NO : | PASCAL 06-0073220 BDSP |
---|---|
ET : | Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe |
AU : | DONOSO MANTKE (O.); SCHMITZ (H.); ZELLER (H.); HEYMAN (P.); PAPA (A.); NIEDRIG (M.) |
DT : | Publication en série; Niveau analytique |
SO : | EUROSURVEILLANCE. EUROPEAN COMMUNICABLE DISEASE QUARTERLY; ISSN 1025-496X; France; Da. 2005-04; Vol. 10; No. 4-6; Pp. 102-106; Bibl. 38 ref.; 3 tabl. |
LA : | Anglais |
EA : | The threat posed by emerging and re-emerging communicable diseases and, more recently, by the intentional release of infectious agents in a susceptible population, has been receiving considerable attention at the national and international levels. Public health efforts to strengthen disease detection, surveillance and control have been intensified. However, clinicians and clinical microbiology laboratories play an important role in the early detection of disease, the identification of the putative agent, and notification of the appropriate authorities. To be effective in this role, laboratories must be specially prepared to handle viral agents safely, and need, among other things, the appropriate rapid and sensitive diagnostic tests. In 1998 the European Network for Diagnostics of "Imported" Viral Diseases (ENIVD) was established. ENIVD presently comprises, as permanent members, 44 expert laboratories in 21 European Union (EU) member states and 4 non-EU countries and is one of the networks on infectious diseases funded by the European Commission. ENIVD fulfils many of the important tasks required for the surveillance and control of imported, rare and emerging viral infections such as the exchange of expertise and the organisation of external quality assurance (EQA) programmes, both of which are needed to improve diagnostics. Here, we summarise the data generated by recent EQA activities focussed on the diagnostics of infections with hantavirus, dengue virus, filovirus, Lassa virus, orthopox virus and the SARS-coronavirus (SARS-CoV). These were carried out between 1999 and 2004 and involved 93 laboratories from 41 countries, including laboratories from additional countries outside of Europe. Particularly the EU-candidate countries and Eastern neighbouring countries will be invited to join the network in the near future. (R.A.) |
CC : | 002B30A11 |
FD : | Voyage; Virus; Réseau; Surveillance sanitaire; Epidémiologie; Qualité; Sérologie; Biologie clinique; Laboratoire; Europe; Diagnostic; Maladie émergente |
ED : | Travel; Virus; Network; Sanitary surveillance; Epidemiology; Quality; Serology; Clinical biology; Laboratory; Europe; Diagnosis; Emerging disease |
SD : | Viaje; Virus; Red; Vigilancia sanitaria; Epidemiología; Calidad; Serología; Biología clínica; Laboratorio; Europa; Diagnóstico; Enfermedad emergente |
LO : | BDSP/InVS |
ID : | 06-0073220 |
Links to Exploration step
Pascal:06-0073220Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe</title>
<author><name sortKey="Donoso Mantke, O" sort="Donoso Mantke, O" uniqKey="Donoso Mantke O" first="O." last="Donoso Mantke">O. Donoso Mantke</name>
<affiliation><wicri:noCountry>no AF</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Schmitz, H" sort="Schmitz, H" uniqKey="Schmitz H" first="H." last="Schmitz">H. Schmitz</name>
<affiliation><wicri:noCountry>no AF</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Zeller, H" sort="Zeller, H" uniqKey="Zeller H" first="H." last="Zeller">H. Zeller</name>
<affiliation><wicri:noCountry>no AF</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Heyman, P" sort="Heyman, P" uniqKey="Heyman P" first="P." last="Heyman">P. Heyman</name>
<affiliation><wicri:noCountry>no AF</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Papa, A" sort="Papa, A" uniqKey="Papa A" first="A." last="Papa">A. Papa</name>
<affiliation><wicri:noCountry>no AF</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Niedrig, M" sort="Niedrig, M" uniqKey="Niedrig M" first="M." last="Niedrig">M. Niedrig</name>
<affiliation><wicri:noCountry>no AF</wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">06-0073220</idno>
<date when="2005-04">2005-04</date>
<idno type="stanalyst">PASCAL 06-0073220 BDSP</idno>
<idno type="RBID">Pascal:06-0073220</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000557</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe</title>
<author><name sortKey="Donoso Mantke, O" sort="Donoso Mantke, O" uniqKey="Donoso Mantke O" first="O." last="Donoso Mantke">O. Donoso Mantke</name>
<affiliation><wicri:noCountry>no AF</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Schmitz, H" sort="Schmitz, H" uniqKey="Schmitz H" first="H." last="Schmitz">H. Schmitz</name>
<affiliation><wicri:noCountry>no AF</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Zeller, H" sort="Zeller, H" uniqKey="Zeller H" first="H." last="Zeller">H. Zeller</name>
<affiliation><wicri:noCountry>no AF</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Heyman, P" sort="Heyman, P" uniqKey="Heyman P" first="P." last="Heyman">P. Heyman</name>
<affiliation><wicri:noCountry>no AF</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Papa, A" sort="Papa, A" uniqKey="Papa A" first="A." last="Papa">A. Papa</name>
<affiliation><wicri:noCountry>no AF</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Niedrig, M" sort="Niedrig, M" uniqKey="Niedrig M" first="M." last="Niedrig">M. Niedrig</name>
<affiliation><wicri:noCountry>no AF</wicri:noCountry>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">EUROSURVEILLANCE. EUROPEAN COMMUNICABLE DISEASE QUARTERLY</title>
<idno type="ISSN">1025-496X</idno>
<imprint><date when="2005-04">2005-04</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">EUROSURVEILLANCE. EUROPEAN COMMUNICABLE DISEASE QUARTERLY</title>
<idno type="ISSN">1025-496X</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Clinical biology</term>
<term>Diagnosis</term>
<term>Emerging disease</term>
<term>Epidemiology</term>
<term>Europe</term>
<term>Laboratory</term>
<term>Network</term>
<term>Quality</term>
<term>Sanitary surveillance</term>
<term>Serology</term>
<term>Travel</term>
<term>Virus</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Voyage</term>
<term>Virus</term>
<term>Réseau</term>
<term>Surveillance sanitaire</term>
<term>Epidémiologie</term>
<term>Qualité</term>
<term>Sérologie</term>
<term>Biologie clinique</term>
<term>Laboratoire</term>
<term>Europe</term>
<term>Diagnostic</term>
<term>Maladie émergente</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The threat posed by emerging and re-emerging communicable diseases and, more recently, by the intentional release of infectious agents in a susceptible population, has been receiving considerable attention at the national and international levels. Public health efforts to strengthen disease detection, surveillance and control have been intensified. However, clinicians and clinical microbiology laboratories play an important role in the early detection of disease, the identification of the putative agent, and notification of the appropriate authorities. To be effective in this role, laboratories must be specially prepared to handle viral agents safely, and need, among other things, the appropriate rapid and sensitive diagnostic tests. In 1998 the European Network for Diagnostics of "Imported" Viral Diseases (ENIVD) was established. ENIVD presently comprises, as permanent members, 44 expert laboratories in 21 European Union (EU) member states and 4 non-EU countries and is one of the networks on infectious diseases funded by the European Commission. ENIVD fulfils many of the important tasks required for the surveillance and control of imported, rare and emerging viral infections such as the exchange of expertise and the organisation of external quality assurance (EQA) programmes, both of which are needed to improve diagnostics. Here, we summarise the data generated by recent EQA activities focussed on the diagnostics of infections with hantavirus, dengue virus, filovirus, Lassa virus, orthopox virus and the SARS-coronavirus (SARS-CoV). These were carried out between 1999 and 2004 and involved 93 laboratories from 41 countries, including laboratories from additional countries outside of Europe. Particularly the EU-candidate countries and Eastern neighbouring countries will be invited to join the network in the near future. (R.A.)</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>1025-496X</s0>
</fA01>
<fA05><s2>10</s2>
</fA05>
<fA06><s2>4-6</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>DONOSO MANTKE (O.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>SCHMITZ (H.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>ZELLER (H.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>HEYMAN (P.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>PAPA (A.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>NIEDRIG (M.)</s1>
</fA11>
<fA17 i1="01" i2="1"><s1>Robert Koch Institut. Berlin.</s1>
<s3>DEU</s3>
</fA17>
<fA17 i1="02" i2="1"><s1>Bernhard Nocht Institute for Tropical Medicine. Department of Virology. Hambourg.</s1>
<s3>DEU</s3>
</fA17>
<fA17 i1="03" i2="1"><s1>Institut Pasteur. Unité Biologie des Infections Virales Emergentes. Lyon.</s1>
<s3>FRA</s3>
</fA17>
<fA17 i1="04" i2="1"><s1>Queen Astrid Military Hospital. Research Laboratory for Vector-Borne Diseases. Bruxelles.</s1>
<s3>BEL</s3>
</fA17>
<fA17 i1="05" i2="1"><s1>Aristotelian University of Thessaloniki. School of Medicine. Department of Microbiology. Thessaloniki.</s1>
<s3>GRC</s3>
</fA17>
<fA20><s1>102-106</s1>
<s3>3 tabl.</s3>
</fA20>
<fA21><s1>2005-04</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>BDSP/InVS</s1>
</fA43>
<fA44><s0>8800</s0>
</fA44>
<fA45><s0>38 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>06-0073220</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="2"><s0>EUROSURVEILLANCE. EUROPEAN COMMUNICABLE DISEASE QUARTERLY</s0>
</fA64>
<fA66 i1="01"><s0>FRA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>The threat posed by emerging and re-emerging communicable diseases and, more recently, by the intentional release of infectious agents in a susceptible population, has been receiving considerable attention at the national and international levels. Public health efforts to strengthen disease detection, surveillance and control have been intensified. However, clinicians and clinical microbiology laboratories play an important role in the early detection of disease, the identification of the putative agent, and notification of the appropriate authorities. To be effective in this role, laboratories must be specially prepared to handle viral agents safely, and need, among other things, the appropriate rapid and sensitive diagnostic tests. In 1998 the European Network for Diagnostics of "Imported" Viral Diseases (ENIVD) was established. ENIVD presently comprises, as permanent members, 44 expert laboratories in 21 European Union (EU) member states and 4 non-EU countries and is one of the networks on infectious diseases funded by the European Commission. ENIVD fulfils many of the important tasks required for the surveillance and control of imported, rare and emerging viral infections such as the exchange of expertise and the organisation of external quality assurance (EQA) programmes, both of which are needed to improve diagnostics. Here, we summarise the data generated by recent EQA activities focussed on the diagnostics of infections with hantavirus, dengue virus, filovirus, Lassa virus, orthopox virus and the SARS-coronavirus (SARS-CoV). These were carried out between 1999 and 2004 and involved 93 laboratories from 41 countries, including laboratories from additional countries outside of Europe. Particularly the EU-candidate countries and Eastern neighbouring countries will be invited to join the network in the near future. (R.A.)</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B30A11</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Voyage</s0>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Travel</s0>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Viaje</s0>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Virus</s0>
<s2>NW</s2>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Virus</s0>
<s2>NW</s2>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Virus</s0>
<s2>NW</s2>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Réseau</s0>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Network</s0>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Red</s0>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Surveillance sanitaire</s0>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Sanitary surveillance</s0>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Vigilancia sanitaria</s0>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Epidémiologie</s0>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Epidemiology</s0>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Epidemiología</s0>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Qualité</s0>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Quality</s0>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Calidad</s0>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Sérologie</s0>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Serology</s0>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Serología</s0>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Biologie clinique</s0>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Clinical biology</s0>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Biología clínica</s0>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Laboratoire</s0>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Laboratory</s0>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Laboratorio</s0>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Europe</s0>
<s2>NG</s2>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Europe</s0>
<s2>NG</s2>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Europa</s0>
<s2>NG</s2>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Diagnostic</s0>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Diagnosis</s0>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Diagnóstico</s0>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Maladie émergente</s0>
<s2>NM</s2>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Emerging disease</s0>
<s2>NM</s2>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Enfermedad emergente</s0>
<s2>NM</s2>
</fC03>
<fN21><s1>044</s1>
</fN21>
</pA>
</standard>
<server><NO>PASCAL 06-0073220 BDSP</NO>
<ET>Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe</ET>
<AU>DONOSO MANTKE (O.); SCHMITZ (H.); ZELLER (H.); HEYMAN (P.); PAPA (A.); NIEDRIG (M.)</AU>
<DT>Publication en série; Niveau analytique</DT>
<SO>EUROSURVEILLANCE. EUROPEAN COMMUNICABLE DISEASE QUARTERLY; ISSN 1025-496X; France; Da. 2005-04; Vol. 10; No. 4-6; Pp. 102-106; Bibl. 38 ref.; 3 tabl.</SO>
<LA>Anglais</LA>
<EA>The threat posed by emerging and re-emerging communicable diseases and, more recently, by the intentional release of infectious agents in a susceptible population, has been receiving considerable attention at the national and international levels. Public health efforts to strengthen disease detection, surveillance and control have been intensified. However, clinicians and clinical microbiology laboratories play an important role in the early detection of disease, the identification of the putative agent, and notification of the appropriate authorities. To be effective in this role, laboratories must be specially prepared to handle viral agents safely, and need, among other things, the appropriate rapid and sensitive diagnostic tests. In 1998 the European Network for Diagnostics of "Imported" Viral Diseases (ENIVD) was established. ENIVD presently comprises, as permanent members, 44 expert laboratories in 21 European Union (EU) member states and 4 non-EU countries and is one of the networks on infectious diseases funded by the European Commission. ENIVD fulfils many of the important tasks required for the surveillance and control of imported, rare and emerging viral infections such as the exchange of expertise and the organisation of external quality assurance (EQA) programmes, both of which are needed to improve diagnostics. Here, we summarise the data generated by recent EQA activities focussed on the diagnostics of infections with hantavirus, dengue virus, filovirus, Lassa virus, orthopox virus and the SARS-coronavirus (SARS-CoV). These were carried out between 1999 and 2004 and involved 93 laboratories from 41 countries, including laboratories from additional countries outside of Europe. Particularly the EU-candidate countries and Eastern neighbouring countries will be invited to join the network in the near future. (R.A.)</EA>
<CC>002B30A11</CC>
<FD>Voyage; Virus; Réseau; Surveillance sanitaire; Epidémiologie; Qualité; Sérologie; Biologie clinique; Laboratoire; Europe; Diagnostic; Maladie émergente</FD>
<ED>Travel; Virus; Network; Sanitary surveillance; Epidemiology; Quality; Serology; Clinical biology; Laboratory; Europe; Diagnosis; Emerging disease</ED>
<SD>Viaje; Virus; Red; Vigilancia sanitaria; Epidemiología; Calidad; Serología; Biología clínica; Laboratorio; Europa; Diagnóstico; Enfermedad emergente</SD>
<LO>BDSP/InVS</LO>
<ID>06-0073220</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000557 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000557 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PascalFrancis |étape= Corpus |type= RBID |clé= Pascal:06-0073220 |texte= Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe }}
This area was generated with Dilib version V0.6.33. |